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Rho-kinase is a key regulator of cytoskeletal events
and a promising drug target in the treatment of vascu-
lar diseases and neurological disorders. Unlike other
proteinkinases,Rho-kinase requiresbothN- andC-ter-
minal extension segments outside the kinase domain
for activity, although the details of this requirement
have been elusive. The crystal structure of an active
Rho-kinase fragment containing the kinase domain
and both the extensions revealed a head-to-head ho-
modimer through the N-terminal extension forming
a helix bundle that structurally integrates the C-termi-
nal extension. This structural organization enables
binding of the C-terminal hydrophobic motif to the N-
terminal lobe, which defines the correct disposition
of helix aC that is important for the catalytic activity.
Thebound inhibitor fasudil significantly alters the con-
formation and, consequently, the mode of interaction
with the catalytic cleft that contains local structural
changes. Thus, both kinase and drug conformational
pliability and stability confer selectivity.
Introduction
Members of the Rho family of small GTPases act as mo-
lecular switches and play pivotal roles in regulating the
actin cytoskeleton. Indeed, their activity influences cell
polarity, cell adhesion, cytokinesis, neurite retraction,
and transcription factor activity (Etienne-Manneville
and Hall, 2002). One Rho effector that has received
a great deal of attention is Rho-kinase (ROKa, Rho-as-
sociated kinase, p160ROCK/ROCK II, or ROCK2) (Leung
et al., 1995; Matsui et al., 1996; Kimura et al., 1996; Ishi-
zaki et al., 1996). This serine/threonine protein kinase
was the first identified target of activated RhoA, and
the first role defined for Rho-kinase was to mediate the
formation of stress fibers and focal adhesions after
*Correspondence: hakosima@bs.naist.jpRhoA activation (Leung et al., 1996; Amano et al.,
1997; Ishizaki et al., 1997). Since then, many contractile
processes in smooth muscle and nonmuscle cells have
been linked to the Rho/Rho-kinase pathway (Kaibuchi
et al., 1999; Riento and Ridley, 2003). Rho-kinase elicits
its effect by facilitating myosin light chain (MLC) phos-
phorylation both directly and indirectly, leading to an in-
crease in phosphorylated MLC. This increase then re-
sults in induction of interactions between actin and
myosin, thereby enhancing the myosin ATPase activity
required for contraction (Amano et al., 1996).
The pathophysiological implications of Rho/Rho-ki-
nase signaling include hypercontraction (abnormal con-
traction of vascular smooth muscle), which is a major
cause of disease such as hypertension and vasospasm
of the coronary and cerebral arteries (Fukata et al.,
2001). Moreover, abnormal activation of this pathway
has been observed in various disorders of the central
nervous system (Mueller et al., 2005). Several specific in-
hibitors of Rho-kinase have been developed to treat
these diseases. The isoquinoline derivative fasudil
(HA-1077) was one of the first small-molecule inhibitors
of Rho-kinase identified (Uehata et al., 1997) and is cur-
rently used to clinically treat cerebral vasospasm, a re-
sult of subarachnoid hemorrhage (Ono-Saito et al.,
1999). Fasudil showed a good selectivity profile toward
Rho-kinase in a study that compared its inhibitory ef-
fects on 27 serine/threonine kinases (Davies et al.,
2000). Rho-kinase inhibitors, including fasudil, have
been shown to induce significant vasodilatory effects
with a variety of therapeutic indications (Hu and Lee,
2005). Notwithstanding the pronounced importance of
the protein in medicine as well as in cell biology, no
three-dimensional structure of the kinase domain of
Rho-kinase has previously been reported.
Rho-kinase (1388 residues) consists of an N-terminal
extension region, a protein kinase domain and its C-ter-
minal extension, a central coiled-coil-forming region en-
compassing the Rho binding region at its C terminus,
and a C-terminal putative pleckstrin homology (PH) do-
main that includes a cysteine-rich subdomain (Fig-
ure 1A). An autoinhibitory mechanism has been pro-
posed for Rho-kinase that involves an intramolecular
interaction between the kinase domain and the C-termi-
nal PH domain in the absence of Rho binding (Amano
et al., 1999; Chen et al., 2002). Rho-kinase has an iso-
zyme, ROCK1 (also known as ROKb/ROCK I), that ex-
hibits 92% sequence identity in the kinase domains.
The tissue distribution of the two enzymes differs:
Rho-kinase is preferentially expressed in brain, whereas
ROCK1 shows the highest expression levels in non-
neuronal tissues. Rho-kinase displays the greatest ho-
mology to myotonic dystrophy kinase (DMPK), DMPK-
related cell division control protein 42 (Cdc42) binding
kinase (MRCK), and citron kinase (CRIK).
Rho-kinase possesses a novel N-terminal extension
to the kinase domain. It has been noted that this exten-
sion is required for catalytic activity ever since it was ini-
tially identified as an activated RhoA target (Leung et al.,
1996) (Figure 1B). Similar N-terminal extensions have
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590Figure 1. Primary Structure of the Rho-
Kinase Extensions
(A) Schematic diagrams of the domains of
Rho-kinase. The protein construct used in
this study is shown in further detail below:
the N-terminal extension is shown in green,
the b-rich N-terminal lobe is shown in
cyan, the helix-rich C-terminal lobe is shown
in blue, and the C-terminal extension is
shown in red. Functionally important motifs
are indicated inside the domains: RBD for
the Rho binding domain, Cys-rich for the pu-
tative Zn binding cysteine-rich domain, P
loop for the phosphate binding loop (or Gly-
cine-rich loop) with the GxGxfG motif (ma-
genta), C loop for the catalytic loop (orange),
A loop for the activation loop (yellow) and the
C-terminal extension (red). The hydrophobic
motif (HM) is marked with a black square.
(B) Sequence alignment of the N-terminal
extensions of Rho-kinase and the related
protein kinases. All sequences are of human
origin: Rho-kinase and ROKb/ROCKI (rho-
kinase a and b, respectively), DMPK, three
subtypes (a, b, and g) of MRCK, and citron
kinase (CRIK). Leucine and aspartate resi-
dues that are conserved among seven kinases are in orange boxes, residues conserved only between Rho-kinases a and b are in blue, and res-
idues conserved among Rho-kinase a proteins from bovine, human, mouse, and rat are in green. Shown above the alignment are the secondary
structure elements (a helices, aA1–aA3) found in the structure of Rho-kinase.
(C) Sequence alignment of the C-terminal extensions of Rho-kinase and the related protein kinases as in (B). Strand b12, which is found in the
Rho-kinase structure, is shown above the alignment.
(D) Chemical structure and atom numbering of fasudil. Fasudil is composed of the planar isoquinoline ring and the pendant ring of seven-mem-
bered homopiperazine linked by a sulfonyl group.been found in MRCK, DMPK, and citron kinase (Bush
et al., 2000; Tan et al., 2001; Madaule et al., 1998), but
precisely how the N-terminal extension affects catalytic
activity remains unknown. Rho-kinase and these related
kinases belong to the AGC family of eukaryotic protein
kinases, which includes cAMP-dependent protein ki-
nase (PKA), PKG, PKC, PKB/Akt, and PDK1. All of the
AGC family members require a C-terminal extension se-
quence outside the kinase domain for catalytic activity
(Peterson and Schreiber, 1999). The C-terminal exten-
sion contains a conserved sequence motif of 6 residues,
FXXF[T/S][F/Y] (where X represents any amino acid res-
idue) (Figure 1C). This motif is often referred to as the C-
terminal ‘‘hydrophobic motif,’’ and its binding to the ki-
nase domain is shown to be essential for activity (Pearl
and Barford, 2002; Newton, 2003).
Here, we have determined the crystal structure of an
active Rho-kinase fragment containing the kinase do-
main and both the N- and C-terminal extensions in com-
plex with the specific inhibitor, fasudil (Figure 1D). Our
structure reveals that the N-terminal extension seg-
ments form a novel, to our knowledge, intermolecular
helix-bundle fold, the capped helix-bundle (CHB) do-
main, which brings the two molecules together to form
a head-to-head homodimer. This dimer arrangement is
consistent with the parallel dimer formation by the
coiled-coil domain. The dimerized kinase domain of
Rho-kinase appears to be in an active conformation in
the absence of phosphorylation. The C-terminal exten-
sion is sandwiched between the CHB domain and the ki-
nase domain so that the hydrophobic motif binds the hy-
drophobic groove on the kinase domain to stabilize the
active state. The activation loop adopts an open confor-
mation that allows nucleotide and substrate binding andsubsequent catalysis. Thus, we have found direct evi-
dence for the mechanistic significance of the N- and
C-terminal extensions to Rho-kinase catalytic activity.
We have also uncovered differences in conformation
of the bound inhibitor between Rho-kinase and PKA,
providing clues for understanding what factors deter-
mine specificity.
Results and Discussion
Overview of the Kinase Domain Structure
The protein construct of Rho-kinase used in this study
consists of an N-terminal 67 residue extension (residues
18–84) and a kinase domain with a C-terminal extension
(residues 85–417) (Figure 1A). The crystal structure of the
Rho-kinase fragment complexed with fasudil was deter-
mined at 2.4 A˚ resolution to an Rcryst of 19.7% (an Rfree of
23.5%) (Table 1). Our structure contains two crystallo-
graphically independent molecules with similar struc-
tures (molecule A and molecule B); the root-mean-
square deviation (rmsd) between the two molecules is
small (0.65 A˚ for 321 Ca-carbon atoms). The overall fold
of the kinase domain of Rho-kinase is similar to that of
other known protein kinases of the AGC family
(Figure 2A). The conserved kinase domain shows the ca-
nonical protein kinase fold—that is, a bilobal structure
with a small N-terminal lobe (residues 85–174) and
a larger C-terminal lobe (residues 175–350). The relative
disposition of the N- and C-terminal lobes represents
a closed form as found in PKA bound to an ATP analog
and a PKI peptide (Figures 2B). Fasudil was identified
in the interlobe cleft that corresponds to the conserved
ATP binding site. The kinase domain of Rho-kinase
was best aligned structurally to that of the closed form
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591of PKA (rmsd of 0.86 A˚ for 193 out of 333 residues)
(Figure S1; see the Supplemental Data available with
this article online).
The N-terminal lobes of Rho-kinase and PKA consist
of common secondary structure elements, a five-
stranded b sheet (strands b1–b5) with two a helices
(aB and aC), while the C-terminal lobe of Rho-kinase,
consisting of eight helices (aD and aI) with seven short
strands (b5D–b11), contains three 1 or 2 residue deletion
sites and three 4 residue insertion sites (Figure 3). The in-
serted residues are in close proximity to additional sec-
ondary structure elements. The additional b10/b11
strand pair appears at the segment that contains the first
and second insertion sites, and the additional helix aGH
is located at the loop between helices aG and aH (the
aG-aH loop) that contains the third insertion. Another in-
sertion is found in the linker between the kinase domain
and the C-terminal extension, which is much longer than
that in PKA. The connection (residues 351–398) between
the C-terminal lobe and the extension creeps up on the
side of the kinase domain from the bottom and crosses
over the top of the N-terminal lobe. Finally, residues
388–395 of the connection running above strands b1
and b2 exhibit high temperature factors and show no in-
terpretable electron density in our crystal.
The N-Terminal Extension Mediates Dimerization
The N-terminal extension folds into three a helices (aA1,
aA2, and aA3) and is associated with the corresponding
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Bond length (A˚) 0.014
Bond angles (º) 1.68
Main chain B factor (A˚2) 1.35
a Data for the outermost resolution shell (2.49–2.40 A˚) are given in pa-
rentheses. Measurements were excluded from scaling and merging
when I/s(I) < 0.
b A subset of data (5%) was excluded from the refinement and was
used for the Rfree calculation.part from the adjacent molecule that is related by the
crystallographic 2-fold axis (Figures 4A and 4B). The
nonpolar contacts around the dyad axis are exemplified
by leucine zipper-like interactions between three leucine
residues (Leu46, Leu47, and Leu53) on helix aA2
(Figure 4C). The first half of helix aA3 is paired with helix
aA2 in an antiparallel manner. Helix aA3 contains a kink in
the middle (at Tyr75), and the rest of the helix is redir-
ected, crossing over helix aA2, to connect to the N-ter-
minal lobe. The long aA2 and aA3 helices run up and
down to form a large hydrophobic surface (w1680 A˚2)
that interacts with the corresponding helices from the
dimerized partner molecule (Figure 4D).
Two short aA1 helices sit on top of the four-helix bun-
dle formed by helices aA2 and aA3 from both protomers
(Figure 4B). These helices serve to stabilize the dimer-
ized domain by capping the hydrophobic core of the
bundle. Thus, the N-terminal extensions in the dimer
structure feature a capped helix-bundle fold, hereafter
referred to as the CHB domain. CHB domain-mediated
dimerization was clearly demonstrated by the results of
gel filtration chromatography, in which the Rho-kinase
protein used in our structural study eluted at a retention
volume consistent with a dimer, whereas the N-terminal
truncated protein (residues 86–417) yielded an elution
profile consistent with a monomer (Figure S2A).
Notably, the leucine residues on helices aA2 are abso-
lutely conserved, not only in Rho-kinase isozymes from
different species, but also in MRCK, citron kinase, and
DMPK (Figure 1B). In Rho-kinase, the C-terminal exten-
sion is directly followed by a long (w700 residues)
coiled-coil region (Figure 1A). Both protomers of the di-
mer point their C termini in the same direction
(Figure 4B). This is consistent with the downstream par-
allel coiled-coil formation indicated by crystal structures
of the coiled-coil region fragments (Shimizu et al., 2003;
Dvorsky et al., 2004), also implied for MRCK from bio-
chemical studies (Tan et al., 2001). Our dimer structure
suggests that full-length active Rho-kinase exists as
an entirely parallel dimer (Figure 4E).
The C-Terminal Extension
The most interesting structural aspect of the Rho-kinase
dimer is that the very end of the C-terminal extension is
situated between the CHB domain and the N-terminal
lobe (Figure 4A). The N-terminal half of the extension
makes contact more closely with the CHB domain
than with the N-terminal lobe, whereas the C-terminal
half is sandwiched between the CHB domain and the
N-terminal lobe and makes contact with both (Figure 4B).
The C-terminal half contains the hydrophobic motif
410FIGFTY415 that is completely embedded in the inter-
face.
Three nonpolar residues (Phe403, Leu408, and Ile411)
of the N-terminal half of the C-terminal extension poke
their hydrophobic side chains into a furrow of the CHB
domain, formed by antiparallel helices—aA2 of one pro-
tomer molecule and aA3 of the other (Figure 5A). These
hydrophobic interactions are fortified by polar interac-
tions, namely, the formation of hydrogen bonds be-
tween the main chains of the extension and the side
chains of the CHB domain, Arg74 from helix aA3, and
Asp48 from helix aA2. Side chain-to-side chain inter-
actions are also present, consisting of intermolecular
Structure
592Figure 2. Overall Structure of the Kinase
Domain of Rho-Kinase and Comparison
with PKA
(A) Ribbon diagram of Rho-kinase (molecules
A). The kinase domain with the C-terminal ex-
tension is shown in cyan (N-terminal lobe),
blue (C-terminal lobe), and red (C-terminal
extension containing the hydrophobic motif).
The N-terminal extension forming the CHB
domain is omitted for clarity. All secondary
structure elements are labeled. The bound
fasudil is shown as a stick model. Five cata-
lytically important residues (Lys121, Glu140,
Asp214, Asn219, and Asp232) in addition to
the potential phosphorylation site in the acti-
vation loop (Thr249) are shown. The func-
tional motifs are shown with the same color
scheme as in Figure 1A; magenta, P loop;
orange, C loop; yellow, A loop. Dotted con-
nections between the N-terminal lobe and
the C-terminal extension are for residues
omitted in model building due to poor elec-
tron density (see text).
(B) Ribbon diagram of PKA (PDB code: 1CDK). The bound ATP analog (AMPPNP) is shown as a stick model. Five catalytically important residues
(Lys72, Glu91, Asp166, Asn171, and Asp184) and the phosphorylated threonine (pThr197) in the activation loop are shown. The functionally sig-
nificant motifs are shown with the same color scheme as in (A). The PKI peptide is not shown for clarity.(Asn406 and Asn67) and intramolecular (Thr414 and
Asp48) hydrogen bonds.
On the other side of the C-terminal extension, Pro409
and three aromatic side chains (Phe410, Phe413, and
Tyr415) of the hydrophobic motif are anchored to the hy-
drophobic groove formed by helices aB–aC and strands
b4–b5 of the N-terminal lobe (Figure 5B). This fixes,
along with a hydrogen bonding network that involves
side chains of conserved residues (specifically, Lys125
from helix aB, Arg141 from helix aC, and Glu160 from
strand b4), helix aC onto the b sheet. The very end resi-
dues, Tyr415 and Tyr416, form a short b strand (b12) next
to strand b4 and participate in sheet formation in the N-
terminal lobe. The conserved residue Thr414, which is
a potential phosphorylation site on the hydrophobic mo-
tif in general, has no electron density corresponding to
a potential phosphate group (Figure S3). Rather, there
is a bridging water molecule between the Thr414 side
chain and the main chain amide group of Gln160 from
strand b4 of the N-terminal lobe (Figure 5B). Conse-
quently, the C-terminal hydrophobic motif and helix aC
are well ordered in our structure.
The CHB domain as a whole statically covers and sta-
bilizes the hydrophobic motif tucked into the hydropho-
bic groove of the N-terminal lobe. Simultaneously, the C-
terminal extension contributes to structural stabilization
of the CHB domain, although they are quite distant in the
primary sequence (>300 residues). These structural as-
pects are consistent with a recent hydrodynamic study
in which both the N- and C-terminal extensions of
Rho-kinase are suggested to be necessary for stable di-
mer formation (Doran et al., 2004).
The Hydrophobic Motif and Catalytic Activity
In our Rho-kinase structure, the hydrophobic motif
bound to the hydrophobic groove on the N-terminal
lobe properly aligns helix aC on the b sheet. As a result
of this alignment, the conserved Glu140 from helix aC
stabilizes catalytically essential Lys121 from strand b3by ion pairing, as seen in the active form of PKA (Glu91
and Lys72) (Figure 2B). This ion pair (hereafter referred
to as the Glu-Lys ion pair), which is a characteristic fea-
ture of the active conformation of protein kinases (Huse
and Kuriyan, 2002; Newton, 2003; Nolen et al., 2004), en-
ables the lysine residue to extend its side chain amino
group toward the binding site for the a- and b-phos-
phates of ATP, the same site where we find fasudil in
our crystal (Figures 2A and 2B). In addition, Ile143 of he-
lix aC stacks onto Phe233 of the conserved Asp-Phe-Gly
(DFG) motif to align the conserved residue Asp232 cor-
rectly. Thus, structurally embedded in the interface be-
tween the CHB domain and the N-terminal lobe, the hy-
drophobic motif defines helix aC at a proper position for
a catalytically active conformation.
Removal of the CHB domain necessarily causes expo-
sure of nonpolar residues (Phe403, Leu408, and Ile411)
within the C-terminal extension, and it would destabilize
its binding to the hydrophobic groove. In fact, an N-ter-
minally truncated, monomeric protein (residues 86–417)
that lacks the CHB domain, but possesses the kinase
domain and the C-terminal extension with the hydro-
phobic motif, has significantly diminished enzymatic ac-
tivity compared to the dimeric protein used for our struc-
tural study (residues 18–417) (Figure S2B). These
nonpolar residues in the hydrophobic motif are specific
for Rho-kinase and the related kinases requiring their N-
terminal extensions for activity, while they are replaced
with polar residues in other AGC kinases that do not re-
quire their N-terminal extensions. A similar loss of activ-
ity was observed for Rho-kinase proteins that lack the
C-terminal extension (Doran et al., 2004). The data are
consistent with the fact that no extensive, direct interac-
tion between the CHB domain and the N-terminal lobe
was observed in our structure. In this way, our structure
has successfully addressed the long-standing question
of why the N-terminal extension is critical for catalytic
activity in Rho-kinase (Leung et al., 1996) as well as in
its closely related kinases (Tan et al., 2001).
Structure of the Rho-Kinase-Fasudil Complex
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The sequences of bovine Rho-kinase and human PKA are aligned based on the structures together with the human ROCK II (Rho-kinase a) and
ROCK I (Rho-kinase b) sequences. Shown above the alignment are the secondary structure elements found in the Rho-kinase structure (mole-
cule A); a helices (aA–aI) are shown as blue cylinders, and b sheets (b1–b12) are shown as green arrows with the residue numbering of bovine
Rho-kinase. Using the same color scheme as in Figure 1A, functionally important motifs are shown below the alignment. Residues that are in
contact with bound fasudil are indicated in orange (positionally conserved between Rho-kinase and PKA, see Experimental Procedures) or ma-
genta boxes (positionally nonconserved).The Activation Loop
The activation loop shares crucial roles in catalysis with
helix aC, which defines formation of the Glu-Lys ion pair
and disposition of the DFG motif. Rho-kinase undergoes
autophosphorylation (Ishizaki et al., 1996; Matsui et al.,
1996) and has a conserved threonine (Thr249) at the cen-
tral phosphorylation position of the activation loop. In
our crystal, Thr249 was not phosphorylated, but the ac-
tivation loop was moved away from the catalytic center,
adopting an open and extended conformation that is
permissive for nucleotide and substrate binding and
subsequent catalysis (Figure 2A). This ordered confor-
mation resembles the structure of activation loops
found in active forms of AGC kinases such as PKA
(Figure 2B), suggesting that the conformation of our di-
meric Rho-kinase protein exists in an active state. In
fact, the catalytic residue Asp214 in the catalytic loop
adopts a proper side chain position and conformation
by hydrogen bonding to Asn219, as in the active form
of PKA (Asp166 and Asn171).
In PKA and most other AGC kinases, the negatively
charged, phosphorylated threonine (Thr197 in PKA) of
the activation loop is flipped toward the inside. This is
anchored by ion pairing with arginine, lysine, and threo-
nine residues (Arg165, Lys189, and Thr195 in PKA) thatform an induced-fit positively charged pocket
(Figure 5C). In Rho-kinase, the arginine (Arg213) is con-
served, but the lysine and threonine residues are re-
placed with nonpolar residues (Met237 and Cys247)
that should fail to interact favorably with the phosphate
group. Moreover, helix aC of PKA possesses a histidine
side chain (His87) in contact with the phosphate group,
whereas this histidine is replaced with Phe136 in Rho-ki-
nase. Therefore, we speculate that anchoring of the
phosphate should be weak in Rho-kinase. This could ac-
count for the fact that our crystallized Rho-kinase pro-
tein was not phosphorylated, although Rho-kinase can
undergo autophosphorylation when it is expressed in
cells.
In our structure, nonphosphorylated Thr249 pro-
truded somewhat toward the solvent region, while the
following P+1 loop virtually adopts the same path as in
PKA. We noticed that Rho-kinase possesses two 4 res-
idue insertion sites at or around the activation loop com-
pared with PKA (Figures 3 and 5C). One is 241ETGM244,
located in the activation loop, and the other is
265QGGD268, located in the loop between helicesaEF and
aF (the aEF-aF loop). The former stabilizes an elongated
activation loop packed on the latter (the insertion-con-
taining segment) between helices aEF and aF without
Structure
594Figure 4. Dimeric Structure of the Rho-Kinase Protein Consisting of the Kinase Domain and the N- and C-Terminal Extensions
(A) Ribbon diagram of the dimer structure of the Rho-kinase protein in the direction looking down the 2-fold axis. The Rho-kinase protein consists
of the N-terminal extension (green for one molecule and orange for the other), the kinase domain (cyan for the N-terminal lobe and blue for the
C-terminal lobe), and the C-terminal extension (red). The bound inhibitors are shown as stick models.
(B) View of the Rho-kinase dimer in an orthogonal direction as in (A). Both the N and C termini are indicated.
(C) Ca-tracing representation of the leucine zipper-like interaction at the core of the dimer interface. Van der Waals contacts between three leu-
cine residues on helix aA2 (Leu46, Leu47, and Leu53) are shown.
(D) Close-up view of the dimerization machinery. A region of the CHB domain and the C-terminal extension enclosed in a box in (B) is shown. The
dimer interface is drawn as a surface and worm model. In one protomer, the molecular surface of hydrophobic residues from the N-terminal ex-
tension helices is colored red.
(E) Schematic diagram of the proposed full-length Rho-kinase structure. Shown on the top is the kinase domains dimerized by the CHB domain
as in (B). The following coiled-coil region and the PH domain are also shown in a gray box. Arrows indicate the active sites of the kinase domains,
which are facing toward the top.phosphorylation (Figure 5C). The latter insertion con-
tains 2 glycine residues and creates a bulged cushion
to alleviate possible structural stress when strand b11
pairs with strand b10. Our structure implies that phos-
phorylation of the activation loop is nonessential for the
Rho-kinase activation.
Phosphate Binding Loop Plasticity for Fasudil
Binding
Fasudil binds to the hydrophobic cleft between the N-
and C-terminal lobes of the kinase domain (Figure 2A).
The planar isoquinoline ring of fasudil is inserted into
the canonical adenine binding pocket of protein kinases,
whereas the seven-membered homopiperazine ring is
placed at the entrance of the cleft, where active residues
are clustered (Figures 6A and 6B). The isoquinoline ring
is situated on a hydrophobic platform (Met172, Leu221,
and Ala231) and is covered by b sheet residues of the N-
terminal lobe (Ile98, Val106, Ala119, and Met169). The
edge of the inhibitor ring makes contact with the aro-
matic rings of Phe384 and Tyr171.
There are a number of contacts between nonpolar
side chains of the cleft and the aromatic ring of the in-
hibitor. We identified 17 residues that have at least 1atom within a distance of 4 A˚ from the bound inhibitor
(Table S1). Most of these Rho-kinase-inhibitor interac-
tions are conserved in the PKA-fasudil complex (Brei-
tenlechner et al., 2003), although the Rho-kinase resi-
dues Ile98, Met172, and Ala231 are replaced with Leu,
Val, and Thr, respectively, in PKA (Figure 3). Interest-
ingly, these rather subtle structural variations have a no-
ticeable effect on the positions and conformations of
the conserved residues (Figure 6C). Such a variation is
exemplified by conserved Leu221, which adopts a sta-
ble rotamer by side chain packing with Met172 and
Ala231, even though the corresponding Leu of PKA
bound to fasudil adopts a rare unstable rotamer config-
uration (Figure 6D). The stable rotamer of Rho-kinase
Leu221 protrudes the terminal methyl group of its side
chain toward the inhibitor isoquinoline ring, resulting
in an increased number of contacts with the isoquino-
line ring (Table S1). This presumably accounts for
specificity.
The most interesting aspect of fasudil binding to Rho-
kinase is that the homopiperazine rings in our complex
differ largely in their disposition and conformation from
the corresponding structure in the PKA-fasudil complex,
although the inserted isoquinoline ring is fixed in the
Structure of the Rho-Kinase-Fasudil Complex
595Figure 5. The C-Terminal Extension and the Activation Loop Share Crucial Roles in Catalysis
(A) Graphical representation of the interaction between the C-terminal extension docked to the CHB domain. A main chain trace of the C-terminal
extension and ribbons of the CHB domain formed by the N-terminal extension are drawn with the same color scheme as in Figure 4A. The C-
terminal extension (red) and helix aA2 (orange) are from the same protomer, while helix aA3 (green) is from the other protomer. The side chains
of three nonpolar residues (Phe403, Leu408, and Ile411) of the C-terminal extension are shown as thick stick models in yellow: these hydrophobic
side chains dock into a gully of antiparallel helices of the CHB domain. Hydrogen bonds are indicated by thin lines.
(B) Graphical representation of the interaction between the C-terminal extension and the N-terminal lobe of the kinase domain. The hydrophobic
motif 410FIGFTY415 of the C-terminal extension (red) is docked into the hydrophobic groove of the N-terminal lobe (blue). Three aromatic side
chains (Phe410, Phe413, and Tyr415) of the hydrophobic motif and Pro409 are shown as thick stick models in yellow; these fix helix aC onto
the b sheet, together with a hydrogen bonding network involving Lys125 from helix aB, Arg141 from helix aC, and Glu160 from strand b4.
Thr414 in molecule B forms an additional hydrogen bond with the side chain of Gln160 as well as the hydrogen bonds shown in the figure.
(C) Comparison of the activation segments between Rho-kinase and PKA. Main chain traces of Rho-kinase (molecule A) and PKA (PDB code:
1CDK) are shown along with residues of the activation segment containing the activation loop (yellow). Ca atoms are shown as magenta balls,
where Rho-kinase possesses insertions compared with PKA. Residue side chains anchoring phosphorylated Thr197 (PKA) are shown as ball-
and-stick models, and hydrogen bonds are indicated as thin lines. The side chains of the corresponding residues and Thr249 in Rho-kinase are
also shown. The b10/b11-strand pairing is unique to our Rho-kinase structure, while that in molecule B is somewhat modified, probably as a result
of crystal packing (Figure S4).pocket by the conserved hydrogen bonding between
the ring nitrogen atom (N7) and the main chain of
Met172 (Figures 7A and 7B). Indeed, replacement of
Rho-kinase Asp176 with Glu127 in PKA is likely the ma-
jor factor accounting for the differences between the
Rho-kinase-fasudil and PKA-fasudil complexes. In
PKA, the homopiperazine amine group (N40) is hydrogen
bonded to the side chain of Glu127 and the main chain
carbonyl group of Glu170. Given the shorter side chain
of Asp176, Rho-kinase requires fasudil major conforma-
tional changes in order to achieve similar interactions
with the amine group (N40). In molecule A of our com-
plex, the homopiperazine ring shifts from the position
seen in PKA to form alternative polar interactions with
the side chains of Asn219 and Asp232 (Figure 7A). In
molecule B, fasudil shifts the homopiperazine ring re-
sulting from two bond rotations on the central sulfur
atom of the sulfonyl group. This conformational change
enables the homopiperazine amine group to form hydro-
gen bonds with the side chain carboxylate of Asp176
and the main chain Asp218 (PKA Glu170) (Figure 7B).In contrast to the interaction in molecule A, where fa-
sudil is likely to recognize the natural conformation of
the Rho-kinase molecule, the interaction with the phos-
phate binding loop (P loop, or glycine-rich loop) in mol-
ecule B appears to involve an induced-fit mechanism
(Figures 6A and 6B). The loop of molecule B folds
down to increase surface complementarity with the
drug. The aromatic ring of Phe103 flips inside the loop
to form a number of contacts with the homopiperazine
ring, capping the hydrophobic pocket in which the inhib-
itor binds. This flap is held in place by a hydrogen bond
between the main chain carbonyl group of Phe103 at the
tip of the loop and the side chain of catalytic Lys121 that
forms an ion pair with Glu140 from helix aC (Figure 7C).
Interestingly, Asp232 of the DFG motif in molecule B
flips up to join Glu140 via ion pairing interactions with
Lys121. In contrast, in molecule A, a bridging water mol-
ecule between Lys121 and Asp232 occupies the same
space that accommodates the side chains of Asp232
and Phe103 in molecule B. Similar water-mediated hy-
drogen bonds were seen in the PKA-fasudil complex
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(A) Stereoview of the nucleotide binding pocket of Rho-kinase molecule A. Residues that interact with fasudil are shown. The inhibitor (carbon
atoms in green, oxygen in red, nitrogen in blue, and sulfur in yellow) is shown along with the Fo 2 Fc electron density map contoured at 2.5s),
which was computed by using phases from a model obtained after simulated annealing with the inhibitor was omitted.
(B) Stereoview of the nucleotide binding pocket of Rho-kinase molecule B. The P loop folds down toward fasudil so that Phe103 makes contact
with the pendant ring of the inhibitor (see text). Color codes are as in (A).
(C) Disposition of the Ca atoms of residues in Rho-kinase and PKA in contact with the bound inhibitor fasudil. The backbone Ca traces are shown
for the superposed catalytic domains of Rho-kinase (molecule A; same color scheme as in Figure 1) and PKA (PDB code: 1Q8W; gray). Each
residue has large and small labels for Rho-kinase and PKA, respectively. The Ca atoms are shown as balls in two colors for Rho-kinase: posi-
tionally conserved in orange, and nonconserved in magenta, as in Figure 3.
(D) Rotamer variation found in the fasudil binding sites. The floor of the binding pocket of Rho-kinase (blue) is formed by Met172, Leu221, and
Ala23. These residues are superposed with the corresponding residues (Val123, Leu173, and Thr183, respectively) of PKA (gray). The side chains
are represented by ball-and-stick models. Leu221 of Rho-kinase adopts a stable rotamer, while the corresponding conserved Leu of PKA bound
to fasudil adopts a rare unstable rotamer configuration by side chain packing with nonconserved residues Val123 and Thr183. The stable rotamer
of Rho-kinase Leu221 protrudes an increased number of contacts with the isoquinoline ring (Table S1).and, therefore, would prevent the phosphate binding
loop from flipping. The aforementioned conformational
change in the inhibitor homopiperazine ring seems to
trigger the side chain flip of Asp232 and the large confor-mational transition of the loop by providing a large
space for the Asp232 and Phe103 side chains. As in
Rho-kinase, flips of the phosphate binding loop were
also found in inhibitor bound protein serine/threonine
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(A) Comparison of fasudil molecules bound to Rho-kinase (molecule A) and PKA (PDB code: 1Q8W). A main chain trace of Rho-kinase (colored as
in Figure 4A) is shown along with segments forming the inhibitor binding site containing the residues interacting with the homopiperazine ring of
fasudil. A transparent main chain trace of superposed PKA (gray) is also shown along with the residues that interact with the homopiperazine
ring. Color codes for the protein and the inhibitor are the same as in Figure 2A. Hydrogen bonds between the inhibitor and the protein are indi-
cated as thin lines. Interaction with different residues in the kinase domain (Asn219 and Asp232 in Rho-kinase; Glu127 and Glu170 in PKA) results
in different conformations of the drug pendant rings between the Rho-kinase and the PKA structures.
(B) Comparison of fasudil molecules bound to Rho-kinase (molecule B) and PKA. In Rho-kinase, fasudil shifts the homopiperazine ring due to two
bond rotations on the central sulfur atom of the sulfonyl group, comprising an approximate 90º rotation around the bond to the isoquinoline ring,
and an approximate 180º rotation around the bond to the pendant ring. These shifts enable the inhibitor in Rho-kinase to form hydrogen bonds
with the same residues as in PKA.
(C) Comparison of the Rho-kinase P loops of molecules A (blue) and B (yellow). The P loop of molecule B folds down toward fasudil, and the
aromatic ring of Phe103 makes contact with the pendant ring of the inhibitor. The main chain carbonyl group of Phe103 of molecules B is hydro-
gen bonded to the side chain amino group of the catalytic lysine Lys121 that forms the ion pair with Glu140 and Asp232 of the DFG motif.kinases (Prade et al., 1997; Gassel et al., 2004) and tyro-
sine kinases such as FGFR and c-Abl (Mohammadi
et al., 1997; Nagar et al., 2003). This loop is known to
be mobile in protein kinases, and it can readily accom-
modate such an induced-fit change upon ligand binding.
The phosphate binding loop plasticity in Rho-kinase has
the effect of increasing contacts when fasudil binds,
which is not seen in the PKA-fasudil complex. This dif-
ference between the two kinases’ plasticity in the phos-
phate binding loops may account for the specificity of
Rho-kinase for fasudil.
Conclusion
Although the kinase domain of eukaryotic protein ki-
nases shares general structural similarities, regulatory
mechanisms that control both catalytic activity and sub-
strate specificity are unique to individual kinases. In this
paper, we showed that the dimer-forming N-terminal ex-
tension of Rho-kinase folds into the CHB domain, which
docks the C-terminal hydrophobic motif onto the N-ter-
minal lobe of the kinase domain. This trapping of the hy-
drophobic motif by dimerization stabilizes the activestate of the kinase domain in the absence of phosphor-
ylation of the hydrophobic motif. Knowledge of this
novel, to our knowledge, domain organization in Rho-ki-
nase should facilitate the further development of inhibi-
tors specifically designed to prevent hydrophobic motif
trapping. The head-to-head dimerization by the CHB
domain is consistent with the previously proposed par-
allel dimer that forms a coiled coil. The nonphosphory-
lated activation loop of Rho-kinase adopts virtually the
same open conformation as PKA after phosphorylation.
This open conformation is stabilized by the extensive in-
teraction between the activation and the aEF-aF loops,
both of which have 4 residue insertions compared with
PKA. Our observation of the nonphosphorylated kinase
domain in an active conformation implies that phos-
phorylation is nonessential for Rho-kinase activation.
A direct structural comparison between the cognate
and noncognate complexes defined the specificity-de-
termining mechanisms of the protein kinase inhibitor.
Notwithstanding the substantial structural similarity be-
tween Rho-kinase and PKA, the proteins exhibit differ-
ent induced-fit responses of their phosphate binding
Structure
598loops to fasudil, and conserved residues from each in-
teract quite differently with the bound inhibitor, which
as a result, perhaps, adopts different conformations in
the two kinases. Understanding these differences in
conformational plasticity might help in the development
of compounds with improved specificity for treating se-
rious vascular and neuronal diseases.
Experimental Procedures
Protein Expression, Purification, and Crystallization
A recombinant 400 residue fragment (residues 18–417) from Rho-ki-
nase was expressed in Sf9 insect cells with a hexa-histidine tag by
using the Bac-to-Bac baculovirus expression system (Life Technol-
ogies). The expressed protein was partially purified from the lysate
of infected cells on Q-Sepharose XL (Amersham Pharmacia Bio-
tech.) and Ni-NTA Superflow (Qiagen) chromatographic columns
at 4ºC. The eluate was concentrated and treated with TEV protease
(Parks et al., 1994) at 4ºC for 24 hr to remove the poly-histidine tag.
The protein was further purified on Superdex 200 and Q-Sepharose
HP columns at 4ºC.
Thin, square, plate-shaped crystals were initially obtained by va-
por diffusion at 20ºC in 1–5 ml hanging drops that contained equal
volumes of a cocktail solution of 7.73 mg/ml protein and 40 mM fasu-
dil and a reservoir solution of 100 mM sodium citrate (pH 5.0) and 0.8
M sodium citrate. Crystals tended to grow as stacks of many thin
plates, and multiple rounds of macroseeding were required to obtain
isolated monolithic crystals with increased thickness. Typically, sin-
gle crystals from the previous cycle were harvested and stored at
20ºC in a solution consisting of the reservoir solution with 5 mM
DTT. After 24 hr of storage, the crystals were extensively washed
in a solution containing 75 mM sodium citrate (pH 5.0), 0.6 M sodium
citrate, and 3.75 mM DTT, and they were seeded into 5 ml of a fresh
cocktail solution containing 1.55 mg/ml protein, 60 mM fasudil,
75 mM sodium citrate (pH 5.0), 0.6 M sodium citrate, and 3.75 mM
DTT. The seeded protein solution was then equilibrated in a sitting
drop against a reservoir solution containing 95 mM sodium citrate
(pH 5.0), 0.76 M sodium citrate, and 4.75 mM DTT.
Another construct (residues 86–417) was designed based on the
obtained structure of the dimeric Rho-kinase protein so as to omit
the N-terminal extension for dimerization. The truncated protein
was purified by using the same series of chromatographic columns
as the dimer protein. The rsk kinase S6 substrate peptide
(RRRLSSLRA) was chemically synthesized.
Structural Determination and Refinement
All of the data were measured from a frozen crystal cryoprotected in
25% (w/v) sucrose. The crystals belong to space group P41212, with
two molecules of the expressed protein per asymmetric unit, and
unit cell dimensions of a = b = 102.53 A˚ and c = 257.19 A˚. A data
set was collected at the synchrotron beamline BL44XU at Spring-8
in Japan. Data processing, phase calculation, density modification,
and model building were carried out in a standard manner (CCP4,
1994; Kleywegt and Jones, 1997; Otwinowski and Minor, 1997)
(Table 1).
The structure was solved by molecular replacement by using Mol-
rep (CCP4, 1994). In selecting an initial search model for molecular
replacement, we performed a protein blast search against the PDB
entries. The most significant hit was cAMP-dependent protein ki-
nase, PKA (1APM); the second and the third were PKB and PDK1, re-
spectively. The NCS restraints were used on the density modifica-
tion, but they were not used in the following structural refinement.
The structure was improved by simulated annealing with CNS
(Bru¨nger et al., 1998) and was refined to 2.4 A˚ resolution by using RE-
FMAC5 (Murshudov et al., 1999) (Table 1). The current model con-
tains 769 amino acid residues in total. The N-terminal regions (resi-
dues 18–26) of both molecules A and B were not included in the final
model because of disorder. In addition, a segment of the connection
between the C-terminal lobe and the C-terminal extension (residues
389–393 of molecule A and residues 388–395 of molecule B) was not
included in the model because of poorly defined electron density.
The model also contains 162 water molecules and 2 inhibitor fasudil
molecules. The stereochemical quality of the model was monitoredby using the program PROCHECK (Laskowski et al., 1993). We have
no outliers of the Ramachandran plot, as judged with PROCHECK.
Structural Inspection
As expected from the sequence similarity between Rho-kinase and
PKA (39% identity), when a DALI search was performed with our ki-
nase structure, it showed the highest ‘‘structural’’ similarity (Z score
of w36.3) to PKA from among all protein kinase structures com-
pared. To find a better structural alignment, we first superposed
the Ca atoms of the catalytic loops (residues 166–171 in PKA and
residues 214–219 in Rho-kinase). This was then improved through it-
erative least-square optimization employing a distance cutoff in
which residues were only included when they were in a segment
of at least 5 contiguous residues, each of which had a Ca less
than 1.5 A˚ apart from its counterpart. As a result, as much as 58%
(193 out of 333 residues) of the Rho-kinase kinase domain was struc-
turally aligned to that of PKA (1Q8W) with an rmsd of 0.86 A˚ (for mol-
ecule A).
In our Rho-kinase structure, we identified 17 residues that have at
least one atom within a distance of 4 A˚ from the bound inhibitor. The
Ca dispositions were compared between Rho-kinase and PKA for
those residues. The overall superposition of 16 Ca pairs gave an
rmsd of 0.56 A˚. Three pairs with the smallest Ca deviations were se-
lected, and a strict superposition with these was performed to deter-
mine the next closest pair. By repeating this process, we incremen-
tally picked up four more residue pairs (that is, eight pairs in total).
Subsequently, the contacting residues were sorted into two subsets
based on positional conservation of the Ca atoms with respect to the
bound fasudil. The ‘‘positionally’’ conserved subset of 8 residues of
Rho-kinase (or of PKA) included Ile98 (Leu49), Val106 (Val57), Ala119
(Ala70), Met169 (Met120), Glu170 (Glu121), Tyr171 (Tyr121), Met172
(Val123), and Phe384 (Phe327) with an rmsd of 0.17 A˚. The ‘‘position-
ally’’ nonconserved 8 residues of Rho-kinase (PKA) included: Gly99
(Gly50), Arg100 (Thr51), Asp176 (Glu127), Asp218 (Glu170), Asn219
(Asn171), Leu221 (Leu173), Ala231 (Thr183), and Asp231 (Asp184).
These residues gave an rmsd of 1.04 A˚ (Figure 6C).
Assay for Catalytic Activity
Kinase reactions with the two fragments of Rho-kinase, residues 18–
417 and 86–417, were carried out in 50 ml kinase buffer (50 mM Tris/
HCl [pH 7.5], 1 mM EGTA, 1 mM EDTA, 1 mM DTT, and 5 mM MgCl2)
containing 100 mM [g-32P]ATP (1–20 GBq/mmol), the indicated con-
centrations of recombinant kinases, and 40 mM rsk kinase S6 sub-
strate peptide (RRRLSSLRA). After a 10 min incubation at 30ºC,
the reaction mixtures were spotted onto Whatman P81 paper and
washed three times with 75 mM phosphoric acid. Incorporation of
32P into the substrate was assessed by scintillation counting.
Supplemental Data
Supplemental Data including a list of protein-fasudil contacts, com-
parison of overall structures between Rho-kinase and PKA, results
of gel filtration and an enzyme assay, the electron density of
The414, and comparison of the activation segments between two
Rho-kinase molecules are available at http://www.structure.org/
cgi/content/full/14/3/589/DC1/.
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